Heterogeneous Effects of G-CSF and GM-CSF on Cell Growth and Ara-C Cytotoxicity in Childhood Leukemias Which Express Myeloid Markers

References

• Schriber J.R., Negrin R.S., Chao N.J., Long G.D., Horning S.J., Blume K.G. The efficacy of granulocyte colony-stimulating factor following autologous bone marrow transplantation for non-Hodgkin's lymphoma with monoclonal antibody purged bone marrow. Leukemia 1993; 7: 1491–1495
   PubMed Web of Science ®Google Scholar
• Morstyn G., Campbell L., Souza L.M., Alton N.K., Keech J., Green M., Sheridan W., Metcalf D., Fox R. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988; 1: 667–672
   PubMed Web of Science ®Google Scholar
• Gabrilove J.L., Jakubowski A., Scher H., Sternberg C., Wong G., Grous J., Yagoda A., Fain K., Moore M. A. S., Clarkson B., Oettgen H.R., Alton K., Welte K., Souza L. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. New Engl. J. Med. 1988; 318: 1414–1422
   PubMed Web of Science ®Google Scholar
• Kojima S., Fukuda M., Miyajima Y., Matsuyama T., Horibe K. Treatment of aplastic anemia in children with recombi-nant human granulocyte colony-stimulating factor. Blood 1991; 77: 937–941
   PubMed Web of Science ®Google Scholar
• Welte K., Zeidler C., Reiter A., Muller W., Odenwald E., Souza L., Riehm H. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood 1990; 75: 1056–1063
   PubMed Web of Science ®Google Scholar
• Hammond W.P., IV, Price T.H., Souza L.M., Dale D.C. Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. N. Engl. J. Med. 1989; 320: 1306–1311
   PubMed Web of Science ®Google Scholar
• Ohno R., Tomonaga M., Kobayashi T., Kanamaru A., Shirakawa S., Masaoka T., Omine M., Oh H., Nomura T., Sakai Y., Hirano M., Yokomaku S., Nakayama S., Yoshida Y., Miura A.B., Morishima Y., Dohy H., Niho Y., Hamajima N., Takaku F. Effect of granulocyte colony stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. N. Engl. J. Med. 1990; 323: 871–877
   PubMed Web of Science ®Google Scholar
• Vellenga E., Young D.C., Wagner K., Wiper D., Ostapovicz D., Griffin J.D. The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia. Blood 1987; 69: 1771–1776
   PubMed Web of Science ®Google Scholar
• Delwel R.D., Salem M., Pellens C., Dorssers L., Wagemaker G., Clark S., Lowenberg B. Growth regulation of human acute myeloid leukemia: effects of five recombinant hematopoietic factors in a serum-free culture system. Blood 1988; 72: 1944–1949
   PubMed Web of Science ®Google Scholar
• Komada Y., Zhou Y.W., Zhang S.L., Azuma E., Sakurai M. Role in growth regulation of cytokines and cytokine receptors in acute Iymphoblastic leukemia expressing myeloid markers. Br. J. Haematol 1993; 84: 408–415
   PubMed Web of Science ®Google Scholar
• Higashigawa M., Komada Y., Washio N., Kuwabara H., Hori H., Ido M., Sakurai M. Recombinant human granulocyte colony-stimulating factor enhanced cytotoxicity of ara-C in ara-C-resistant leukemic cells from a patient with biphenotypic leukemia in cell kinetic quiescence. Leukemia Res. 1992; 16: 1049–1054
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Behm F.G., Singh B., Rivera G.K., Schell M.J., Roberts W.M., Crist W.M., Mirro J., Jr. Myeloid-as-sociated antigen expression lacks prognostic value in childhood acute Iymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood 1990; 75: 198–202
   PubMed Web of Science ®Google Scholar
• Wiersma S.R., Ortega J., Sobel E., Weinberg K. Clinical importance of myeloid-antigen expression in acute Iymphoblastic leukemia of childhood. N. Engl. J. Med. 1991; 324: 800–808
   PubMed Web of Science ®Google Scholar
• Lenkei R., Bjork O., Ost A., Biberfeld P. Expression of CD 15 as predictor of relapse in children with acute Iymphoblastic leukemia of the pre-B type. Leukemia Res. 1991; 15: 189–194
   PubMed Web of Science ®Google Scholar
• Bennett J.M., Catovsky D., Daniel M.-T., Flandrin G., Gallon D. A. G., Gralnick H.R., Sultan C. Proposals for the classification of the acute leukemias French-American-British (FAB) co-operative group. Br. J. Haematol. 1976; 33: 451–458
   PubMed Web of Science ®Google Scholar
• Eguchi K., Sasaki S., Tamura T., Sasaki Y., Shinkai T., Yamada K., Soejima Y., Fukuda M., Fujihara Y., Kunitou H., Tobinai K., Ohtsu T., Suemasu K., Takaku F., Saijo N. Dose escalation study of recombinant human granulocyte colony-stimulating factor (KRN 8601) in patients with advanced malignancy. Cancer Res. 1989; 49: 5221–5224
   PubMed Web of Science ®Google Scholar
• Pieters R., Loonen A.H., Huismans D.R., Broekema G.J., Dirven M. W. J., Heyenbrok M.W., Veerman A. J. P. In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions. Blood 1990; 76: 2327–2336
   PubMed Web of Science ®Google Scholar
• Higashigawa M., Ido M., Ohkubo T., Kawasaki H., Kamiya H., Sakurai M., Taniguchi K., Hamazaki M. Increased sensitivity to 1 -P-D-arabinofuranosylcytosine in P388 murine leukemic cells resistant to etoposide. Leukemia Res. 1989; 13: 39–42
   PubMed Web of Science ®Google Scholar
• Miyauchi J., Kelleher C.A., Wang C., Minkin S., McCullock E.A. Growth factors influence the sensitivity of leukemic stem cells to cytosine arabinoside in culture. Blood 1989; 73: 1272–1278
   PubMed Web of Science ®Google Scholar
• Bhalla K., Holladay C., Arlin Z., Grant S., Ibrado A.M., Jasiok M. Treatment with interleukin-3 granulocyte-macrophase colony-stimulating factors improves the selectivity of ara-C in vitro against acute myeloid leukemia blasts. Blood 1991; 78: 2674–2679
   PubMed Web of Science ®Google Scholar
• Teboekhorst P. A. W., Lowenberg B., Vlastuin M., Sonneveld P. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation. Leukemia 1993; 7: 1191–1198
   PubMed Web of Science ®Google Scholar
• Bettelheim P., Andreef V.M., Tafuri A., Haimi J., Gorischek C., Muhm M., Sillaber Ch., Haas O., Vieder L., Maurer D., Schulz G., Speiser W., Geissler K., Kier P., Hinterberger W., Lechner K. Recombinant human granulocyte-macrophase colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia. Blood 1991; 77: 700–711
   PubMed Web of Science ®Google Scholar
• Tattersall M. N. H., Ganeshaguru K., Hoffbrand A.V. Mechanisms of resistance of human acute leukaemia cells to cytosine arabinosine. Br. J. Haematol 1974; 27: 39–46
   PubMed Web of Science ®Google Scholar
• Harris A.W., Reynolds E.C., Finch L.R. Effect of thymidine on the sensitivity of cultured mouse tumor cells to 1 -β-D-arabinofuranosylcytosine. Cancer Res. 1979; 39: 538–541
   PubMed Web of Science ®Google Scholar
• Robert de Saint Vincent B., Buttin G. Studies on l-β-D-arabinofuranosylcytosine-resistant mutants of Chinese hamster fibroblasts. IV. Altered regulation of CTP synthetase generates ara-binosylcytosine and thymidine resistance. Biochem. Biophys. Acta. 1980; 610: 352–359
   Web of Science ®Google Scholar